Insider Transactions in Q2 2024 at Terns Pharmaceuticals, Inc. (TERN)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 31
2024
|
Mark J. Vignola Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
4,791
+4.95%
|
$19,164
$4.44 P/Share
|
|
May 31
2024
|
Seokho Bryan Yoon COO and General Counsel |
BUY
Open market or private purchase
|
Direct |
4,791
+4.95%
|
$19,164
$4.44 P/Share
|
|
Apr 03
2024
|
Vivo Opportunity, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
138,066
-1.85%
|
$828,396
$6.2 P/Share
|
|
Apr 02
2024
|
Vivo Opportunity, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
101,480
-1.34%
|
$608,880
$6.65 P/Share
|
|
Apr 01
2024
|
Vivo Opportunity, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
181,117
-2.34%
|
$1,086,702
$6.99 P/Share
|